Juan de Dios Alfonso
Research Subjects
Research Interests
Juan de Dios Alfonso has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ali Mehdi
Cleveland Clinic
1 shared publication - José Manuel Moreno-Mirón
Departamento de Oncología y Hematología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga 15, Col. Belisario Domínguez Sección XVI, Tlalpan, 14080 Mexico City, Mexico
1 shared publication - Moises Auron
Department of Hospital Medicine Cleveland Clinic Cleveland Ohio USA
1 shared publication Tyler White
Cleveland Clinic
1 shared publication
Latest Publications
- Open Access
- 1 April 2026
- Published by Department of Medicine, Warren Alpert Medical School at Brown University in Journal of Brown Hospital Medicine
- Vol. 5 (2)
Thrombotic Microangiopathy And Hypertensive Emergency After Cocaine Use: A Case Report
A patient in her early 60s presented with hypertensive emergency, microangiopathic hemolytic anemia, thrombocytopenia, and non-oliguric acute kidney injury (AKI) after recent cocaine use. The evaluation demonstrated schistocytes, a Coombs-negative hemolysis pattern, and preserved ADAMTS13 activity, making TTP unlikely. Kidney biopsy confirmed acute thrombotic microangiopathy (TMA) and excluded alternative intrinsic renal pathologies. Autoimmune and infectious workup was unrevealing. Although cocaine exposure temporally preceded presentation, malignant hypertension and complement activation may represent overlapping and potentially synergistic mechanisms rather than a single unifying etiology. Blood pressure control improved hemodynamics, but kidney function continued to worsen, and soluble C5b-9 (sC5b-9) was elevated. Eculizumab was initiated empirically after appropriate vaccination due to persistent renal dysfunction despite blood pressure optimization, recognizing that sC5b-9 is not specific for atypical HUS and may be elevated in secondary TMAs. Renal function subsequently stabilized, and the patient remained dialysis-free at three-month follow-up.
- 1 April 2026
- Published by Department of Medicine, Warren Alpert Medical School at Brown University in Journal of Brown Hospital Medicine
- Vol. 5 (2)
Open AccessThrombotic Microangiopathy And Hypertensive Emergency After Cocaine Use: A Case Report
A patient in her early 60s presented with hypertensive emergency, microangiopathic hemolytic anemia, thrombocytopenia, and non-oliguric acute kidney injury (AKI) after recent cocaine use. The evaluation demonstrated schistocytes, a Coombs-negative hemolysis pattern, and preserved ADAMTS13 activity, making TTP unlikely. Kidney biopsy confirmed acute thrombotic microangiopathy (TMA) and excluded alternative intrinsic renal pathologies. Autoimmune and infectious workup was unrevealing. Although cocaine exposure temporally preceded presentation, malignant hypertension and complement activation may represent overlapping and potentially synergistic mechanisms rather than a single unifying etiology. Blood pressure control improved hemodynamics, but kidney function continued to worsen, and soluble C5b-9 (sC5b-9) was elevated. Eculizumab was initiated empirically after appropriate vaccination due to persistent renal dysfunction despite blood pressure optimization, recognizing that sC5b-9 is not specific for atypical HUS and may be elevated in secondary TMAs. Renal function subsequently stabilized, and the patient remained dialysis-free at three-month follow-up.